Prediction of Length of Stay of First-Ever Ischemic Stroke

Background and Purpose— Accurate information about hospital resource utilization is necessary for management of healthcare service. The purpose of this study was to determine the demographic and clinical predictors of length of hospital stay (LOS) of acute care hospitalization for first-ever ischemic stroke patients. Methods— A group of 330 patients who suffered from first-ever ischemic stroke and were consecutively admitted to a medical center in southern Taiwan were followed prospectively. Because our intention was to identify the major predictors of LOS from the information available at admission, we evaluated only those factors that could be assessed at the time of admission. Univariate analysis and multiple regression analysis were used to identify the main predictors of LOS. Results— The median LOS was 7 days (mean, 11 days; range, 1 to 122 days). Among the prespecified demographic and clinical characteristics, National Institutes of Health Stroke Scale (NIHSS) score at admission, the quadratic term of the initial NIHSS score, modified Barthel Index score at admission, small-vessel occlusion stroke, sex, and smoking were the main explanatory factors for LOS. In particular, for each 1-point increase in the total score of NIHSS, LOS increased approximately 1 day for patients with mild or moderate (score 0 to 15 points) neurological impairments, while LOS decreased approximately 1 day for patients with severe (score >15 points) neurological impairments. Conclusions— The severity of stroke, as rated by the total score on NIHSS, is an important factor that influences LOS after acute stroke hospitalization.

[1]  C. Fan,et al.  Hospital-based stroke care in Ireland: results from one regional register , 2000, Irish journal of medical science.

[2]  T. Strom,et al.  Loss of Renal Phosphate Wasting in a Child with Autosomal Dominant Hypophosphatemic Rickets Caused by a FGF23 Mutation , 2002, Hormone Research in Paediatrics.

[3]  H. Adams,et al.  Ensuring Reliability of Outcome Measures in Multicenter Clinical Trials of Treatments for Acute Ischemic Stroke: The Program Developed for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) , 1994, Stroke.

[4]  B. Cesana,et al.  An analysis of the costs of ischemic stroke in an Italian stroke unit , 1999, Neurology.

[5]  K. Pettigrew,et al.  Progression in acute stroke: value of the initial NIH stroke scale score on patient stratification in future trials. , 1999, Stroke.

[6]  J Lipscomb,et al.  Inpatient costs of specific cerebrovascular events at five academic medical centers. , 1996, Neurology.

[7]  J. Jarvik,et al.  Inpatient costs, length of stay, and mortality for cerebrovascular events in community hospitals , 2001, Neurology.

[8]  Daniel B. Mark,et al.  TUTORIAL IN BIOSTATISTICS MULTIVARIABLE PROGNOSTIC MODELS: ISSUES IN DEVELOPING MODELS, EVALUATING ASSUMPTIONS AND ADEQUACY, AND MEASURING AND REDUCING ERRORS , 1996 .

[9]  T. Olsen,et al.  Acute stroke care and rehabilitation: an analysis of the direct cost and its clinical and social determinants. The Copenhagen Stroke Study. , 1997, Stroke.

[10]  P. Karanjia,et al.  Accuracy of initial stroke subtype diagnosis in the TOAST study , 1995, Neurology.

[11]  W R Clarke,et al.  Baseline NIH Stroke Scale score strongly predicts outcome after stroke , 1999, Neurology.

[12]  H. Adams,et al.  Interphysician agreement in the diagnosis of subtypes of acute ischemic stroke , 1993, Neurology.

[13]  F. Harrell,et al.  Prognostic/Clinical Prediction Models: Multivariable Prognostic Models: Issues in Developing Models, Evaluating Assumptions and Adequacy, and Measuring and Reducing Errors , 2005 .

[14]  D G Altman,et al.  What do we mean by validating a prognostic model? , 2000, Statistics in medicine.

[15]  Xin Qun Wang,et al.  A predictive risk model for outcomes of ischemic stroke. , 2000, Stroke.

[16]  J. Caro,et al.  Predicting Treatment Costs After Acute Ischemic Stroke on the Basis of Patient Characteristics at Presentation and Early Dysfunction , 2001, Stroke.

[17]  Joseph P. Broderick,et al.  Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. , 1995 .

[18]  A. Alexandrov,et al.  Cost of Acute Stroke Care in Toronto, Canada , 1994, Stroke.

[19]  G. Samsa,et al.  Epidemiology of recurrent cerebral infarction: a medicare claims-based comparison of first and recurrent strokes on 2-year survival and cost. , 1999, Stroke.

[20]  N. Venketasubramanian,et al.  Hospital Costs for Stroke Care in Singapore , 2000, Cerebrovascular Diseases.

[21]  D. Kleinbaum,et al.  Applied Regression Analysis and Other Multivariate Methods , 1978 .

[22]  C. Lan,et al.  Incidence of Stroke in Taiwan , 1992, Stroke.